{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:35:53Z","timestamp":1790739353398,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01DA047713"],"award-info":[{"award-number":["U01DA047713"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012864","name":"Biomedical Research Institute of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017046","name":"School of Medicine, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bcp.2022.115109","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T20:59:27Z","timestamp":1653685167000},"page":"115109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Substrate-selective positive allosteric modulation of PTPRD\u2019s phosphatase by flavonols"],"prefix":"10.1016","volume":"202","author":[{"given":"Ian M.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlissa","family":"Marez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Dokladny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Smoake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5632-2426","authenticated-orcid":false,"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2022.115109_b0005","first-page":"1673","article-title":"Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities","volume":"1832","author":"Hendriks","year":"2013","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.bcp.2022.115109_b0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/bi401223r","article-title":"Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases","volume":"53","author":"Selner","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2022.115109_b0015","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/anie.200461517","article-title":"Inhibitors of protein tyrosine phosphatases: next-generation drugs?","volume":"44","author":"Bialy","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/nyas.14002","article-title":"PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes","volume":"1451","author":"Uhl","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2022.115109_b0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2016.03.030","article-title":"Expression of receptor protein tyrosine phosphatase delta, PTPdelta, in mouse central nervous system","volume":"1642","author":"Shishikura","year":"2016","journal-title":"Brain Res."},{"issue":"24","key":"10.1016\/j.bcp.2022.115109_b0030","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1111\/febs.15666","article-title":"Roles of type IIa receptor protein tyrosine phosphatases as synaptic organizers","volume":"288","author":"Fukai","year":"2021","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bcp.2022.115109_b0035","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/mp.2017.20","article-title":"Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies","volume":"23","author":"Chibnik","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/jcm9010180","article-title":"Genome-Wide Association Study of Opioid Cessation","volume":"9","author":"Cox","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.bcp.2022.115109_b0045","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41386-021-01097-0","article-title":"Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study","volume":"46","author":"Biernacka","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.bcp.2022.115109_b0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1474-4422(17)30327-7","article-title":"Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis","volume":"16","author":"Schormair","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2022.115109_b0055","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2015.00017","article-title":"Mouse model for PTPRD associations with WED\/RLS and addiction: reduced expression alters locomotion, sleep behaviors and cocaine-conditioned place preference","author":"Drgonova","year":"2015","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115109_b0060","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.molonc.2016.03.003","article-title":"Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans","volume":"10","author":"Mitchell","year":"2016","journal-title":"Mol. Oncol."},{"issue":"45","key":"10.1016\/j.bcp.2022.115109_b0065","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.1073\/pnas.1720446115","article-title":"Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist","volume":"115","author":"Uhl","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bcp.2022.115109_b0070","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/emboj\/19.12.2775","article-title":"Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice","volume":"19","author":"Uetani","year":"2000","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0075","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.bcp.2022.115109_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/proteomes3030160","article-title":"Complementary PTM Profiling of Drug Response in Human Gastric Carcinoma by Immunoaffinity and IMAC Methods with Total Proteome Analysis","volume":"3","author":"Stokes","year":"2015","journal-title":"Proteomes"},{"issue":"3","key":"10.1016\/j.bcp.2022.115109_b0085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/ac026117i","article-title":"Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics","volume":"75","author":"Rappsilber","year":"2003","journal-title":"Anal. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2022.115109_b0090","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1074\/mcp.T500030-MCP200","article-title":"Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap","volume":"4","author":"Olsen","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.bcp.2022.115109_b0095","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1073\/pnas.0609836104","article-title":"Large-scale phosphorylation analysis of mouse liver","volume":"104","author":"Vill\u00e9n","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pmic.201200439","article-title":"Comet: an open-source MS\/MS sequence database search tool","volume":"13","author":"Eng","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2022.115109_b0105","doi-asserted-by":"crossref","unstructured":"B. MacLean, et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968 (2010).","DOI":"10.1093\/bioinformatics\/btq054"},{"key":"10.1016\/j.bcp.2022.115109_b0110","doi-asserted-by":"crossref","unstructured":"I.M. Henderson, et al., Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development, Biochem. Pharmacol. 195, 114868 (2022).","DOI":"10.1016\/j.bcp.2021.114868"},{"issue":"2-3","key":"10.1016\/j.bcp.2022.115109_b0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10969-007-9036-1","article-title":"Structural genomics of protein phosphatases","volume":"8","author":"Almo","year":"2007","journal-title":"J. Struct. Funct. Genomics"},{"key":"10.1016\/j.bcp.2022.115109_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018934","article-title":"Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors","volume":"6","author":"Raveh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2022.115109_b0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.20041890","article-title":"Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45","volume":"201","author":"Nam","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.bcp.2022.115109_b0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/prot.22716","article-title":"Sub-angstrom modeling of complexes between flexible peptides and globular proteins","volume":"78","author":"Raveh","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.bcp.2022.115109_b0135","series-title":"Schr\u00f6dinger Release 2019\u20134: Protein Preparation Wizard; Epik; Impact; Prime; Glide; LigPrep; Induced Fit Docking protocol","author":"Anonymous","year":"2019"},{"issue":"3","key":"10.1016\/j.bcp.2022.115109_b0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bcp.2022.115109_b0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2022.115109_b0150","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115109_b0155","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115109_b0160","unstructured":"https:\/\/statrek.com\/online-calculator\/hypergeometric.aspx."},{"issue":"10","key":"10.1016\/j.bcp.2022.115109_b0165","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/35096019","article-title":"A decade of CDK5","volume":"2","author":"Dhavan","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115109_b0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2022.115109_b0175","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1242\/jcs.147553","article-title":"Cdk5 activity in the brain - multiple paths of regulation","volume":"127","author":"Shah","year":"2014","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.bcp.2022.115109_b0180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jnr.21523","article-title":"Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216\/279","volume":"86","author":"Sim\u00f3n","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.bcp.2022.115109_b0185","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.neurobiolaging.2009.07.007","article-title":"c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice","volume":"32","author":"Cancino","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"32","key":"10.1016\/j.bcp.2022.115109_b0190","doi-asserted-by":"crossref","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","article-title":"An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease","volume":"288","author":"Cavallini","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/abio.1993.1231","article-title":"A general peptide substrate for protein tyrosine phosphatases","volume":"211","author":"Daum","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2022.115109_b0200","unstructured":"Allen brain institute single cell RNAseq data."},{"key":"10.1016\/j.bcp.2022.115109_b0205","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104150","article-title":"Splice-dependent trans-synaptic PTPdelta-IL1RAPL1 interaction regulates synapse formation and non-REM sleep","volume":"39","author":"Park","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bmcl.2015.11.026","article-title":"Identification of novel protein tyrosine phosphatase sigma inhibitors promoting neurite extension","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2022.115109_b0220","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1074\/jbc.275.6.4066","article-title":"Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1","volume":"275","author":"Yang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115109_b0225","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1074\/mcp.RA119.001716","article-title":"Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2","volume":"18","author":"Drexler","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2022.115109_b0230","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.1401841","article-title":"Protein tyrosine phosphatase receptor type gamma is a JAK phosphatase and negatively regulates leukocyte integrin activation","volume":"194","author":"Mirenda","year":"2015","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2022.115109_b0235","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.celrep.2018.02.038","article-title":"Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling","volume":"22","author":"Batth","year":"2018","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.bcp.2022.115109_b0240","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbt.2015.08.002","article-title":"Alterations in the phosphoproteomic profile of cells expressing a non-functional form of the SHP2 phosphatase","volume":"33","author":"Corallino","year":"2016","journal-title":"N Biotechnol."},{"issue":"12","key":"10.1016\/j.bcp.2022.115109_b0245","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1074\/mcp.M113.028886","article-title":"Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction","volume":"12","author":"Walls","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.bcp.2022.115109_b0250","article-title":"Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2022.115109_b0255","doi-asserted-by":"crossref","unstructured":"E. Shishtar, G.T. Rogers, J.B. Blumberg, R. Au, P.F. Jacques, Long-term dietary flavonoid intake and risk of Alzheimer disease and related dementias in the Framingham Offspring Cohort. Am. J. Clin. Nutr. 10.1093\/ajcn\/nqaa079 (2020).","DOI":"10.1093\/ajcn\/nqaa079"},{"key":"10.1016\/j.bcp.2022.115109_b0260","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1007614613771","article-title":"Intake of flavonoids and risk of dementia","volume":"16","author":"Commenges","year":"2000","journal-title":"Eur. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115109_b0265","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1017\/S1368980009992990","article-title":"Flavonoid intake and disability-adjusted life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries","volume":"13","author":"Beking","year":"2010","journal-title":"Public Health Nutr."},{"issue":"5","key":"10.1016\/j.bcp.2022.115109_b0270","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/JGP.0b013e3181c65250","article-title":"Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins","volume":"18","author":"Hughes","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2022.115109_b0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/WNR.0000000000000594","article-title":"Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients","volume":"27","author":"Nakagawa","year":"2016","journal-title":"NeuroReport"},{"issue":"16","key":"10.1016\/j.bcp.2022.115109_b0280","doi-asserted-by":"crossref","first-page":"e1749","DOI":"10.1212\/WNL.0000000000008981","article-title":"Dietary flavonols and risk of Alzheimer dementia","volume":"94","author":"Holland","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bcp.2022.115109_b0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/ijms21020493","article-title":"Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies","volume":"21","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2022.115109_b0290","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/molecules24122287","article-title":"Preventive Effect of Quercetin in a Triple Transgenic Alzheimer's Disease Mice Model","volume":"24","author":"Paula","year":"2019","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bcp.2022.115109_b0295","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13765-016-0217-0","article-title":"Quercetin and quercetin-3-\u03b2-d-glucoside improve cognitive and memory function in Alzheimer\u2019s disease mouse","volume":"59","author":"Kim","year":"2016","journal-title":"Appl. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2022.115109_b0300","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11064-014-1304-4","article-title":"Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease","volume":"39","author":"Liang","year":"2014","journal-title":"Neurochem. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:12:53Z","timestamp":1762096373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":59,"alternative-id":["S0006295222002039"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115109","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substrate-selective positive allosteric modulation of PTPRD\u2019s phosphatase by flavonols","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115109"}}